The news is rife with reports of a new drug-resistant “superbug”–striking fear into the hearts of parents and employers alike. The word on the street is that MRSA (methicillin-resistant Staphylococcus aureus) is unresponsive to most common antibiotics, deadly, and quickly headed for a town near you.
Is it really as bad as all that? And, if so, what’s the best way to prepare your workplace for the worst?
Order this fact-filled, hype-free conference recording all about this new threat. Our speakers–both experts at the U.S. Centers for Disease Control and Prevention (CDC)–will strip away the half-truths and explain the hard facts of what you need to know about MRSA.
You and your colleagues will learn:
- What MRSA is, and how it spreads from person to person
- How to recognize the signs and symptoms of MRSA infection
- The potential impact on your workplace numbers if MRSA hits
- The best infection control strategies to stop the spread of MRSA
- Practical tips you can use at your workplace, including strategies for keeping contagious employees home
- Current trends in the emergence and spread of infectious diseases
- How to handle return-to-work issues for employees with MRSA
- Current gaps in the medical understanding of MRSA, and how these affect response
This audio conference was recorded on Wednesday, February 13, 2008
About Your Speaker:
Jeffrey Hageman, MHS, is an epidemiologist in the Division of Healthcare Quality Promotion, National Center for Preparedness, Detection and Control of Infectious Diseases, at the CDC. Hageman completed his undergraduate degree in microbiology at Miami University and Master of Health Science in infectious disease epidemiology from Johns Hopkins School of Hygiene and Public Health. He joined CDC in 1998 and has been with the Division of Healthcare Quality Promotion, formerly the Hospital Infections Program, since then.
In his current position, Hageman is one of the CDC subject matter experts for Staphylococcus aureus and is responsible for coordinating and conducting activities related to S. aureus. These activities include surveillance, field investigations, epidemiologic studies, laboratory testing, and public health management (e.g., outbreak response and control) of both vancomycin-resistant S. aureus and methicillin-resistant S. aureus (MRSA) in the community and healthcare settings.
Approved for Recertification Credit
This program has been approved for 1.5 recertification credit hours toward PHR and SPHR recertification through the Human Resource Certification Institute (HRCI). For more information about certification or recertification, please visit the HRCI homepage at www.hrci.org.
